Detalhe da pesquisa
1.
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
Br J Haematol
; 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38654443
2.
Impact of the International Consensus Classification of myelodysplastic syndromes.
Br J Haematol
; 201(3): 443-448, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36575970
3.
Is race important in genomic classification of hematological neoplasms?
Hematol Oncol
; 39(5): 728-732, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34392561
4.
Comparison of Levitt's CO breath test and the 15 N-glycine labeling technique for measuring the lifespan of human red blood cells.
Am J Hematol
; 96(10): 1232-1240, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34265098
5.
Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
BMC Immunol
; 21(1): 10, 2020 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32138642
6.
Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis.
Ann Hematol
; 97(9): 1519-1526, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29946906
7.
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations.
Hematology
; 29(1): 2338509, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38597818
8.
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
Leukemia
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38714876
9.
Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy.
Leuk Res Rep
; 19: 100367, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36968263
10.
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
Cell Rep Med
; 4(8): 101160, 2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37586319
11.
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.
Leukemia
; 36(12): 2875-2882, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36224330
12.
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes.
Exp Hematol Oncol
; 11(1): 73, 2022 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36253799
13.
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
Cancer Res Commun
; 2(4): 258-276, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36873623
14.
Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience.
Leuk Res
; 90: 106299, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32035354
15.
Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
Hematology
; 25(1): 341-347, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32915111
16.
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement.
Leuk Lymphoma
; 64(9): 1605-1610, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37354441
17.
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression.
Blood Cancer J
; 13(1): 56, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37080954
18.
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.
Blood Cancer J
; 11(9): 154, 2021 09 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34535626